top of page
News


adularia is presenting at the biotech europe forum
We are pleased to announce that Adularia has been selected to present at the Biotech Europe Forum 2025 , taking place on October 8–9 in...
Adularia
Aug 7, 20251 min read


Adularia to Present at EuCompChem 2025 in Naples
We are excited to announce that Adularia has been selected to present at the prestigious European Conference on Computational &...
Adularia
Aug 7, 20251 min read


we won the top 100 public voting in the biotech category
We are beyond excited to share that Recolony has won the Top 100 Swiss Startups Public Voting 2024 in the Biotech category ! This award...
Recolony
Sep 5, 20241 min read


Recolony among the top 100 swiss startups 2024
We’re Proud to Be Named One of the Top 100 Swiss Startups in 2024! Being included in this prestigious list is a testament to the hard...
Recolony
Sep 5, 20241 min read


Recolony is among the Top 3 biotech startups that are leading the Top100 public voting 2024
The voting process will be opened until July 21 2024. You still have time to cast your vote using your LinkedIn account. You can vote for...
Adularia
May 13, 20241 min read


Recolony among the Top100 Swiss Startups
Recolony enters the prestigious Top100 Swiss Startups ranking as newcomer in its first year of existence. The TOP 100 Swiss Startup Award...
Recolony
Sep 9, 20231 min read


Recolony receives CHF 150,000 from Venture Kick
Recolony wins the Stage III of Venture Kick. Recolony will invest the CHF 150,000 awarded by Venture Kick to advance our small molecule...
Recolony
Feb 23, 20231 min read


Recolony gets support from InnoBooster
The InnoBooster program from Gebert Rüf Stiftung aims at speeding up innovative, science-based deep tech businesses which have already...
Recolony
Nov 29, 20221 min read


Our CEO wins the Falling Walls Breakthrough of Year in the Emerging Talents Category
Ana Montalban-Arques wins the Breakthrough of the Year in the Emerging Talents Category with the presentation “Breaking the Wall of...
Recolony
Nov 7, 20211 min read
bottom of page
